Funded Grants

PI Name Sort ascending PI Organization Title Grant Number Initiative Program Official
Somers, Tamara J

Duke University
United States

A Mobile Health Behavioral Pain Intervention Protocol for Breast Cancer Patients with Pain in Medically Underserved Communities: A Randomized Controlled Trial 5R01CA237892-05
Sohl, Stephanie Jean

Wake Forest University Health Sciences
United States

REmotely-delivered Supportive Programs for Improving surgical pain and disTrEss (RESPITE) 5R01CA266995-02 PAR-21-035 (R01 Clinical Trial Required) Goli Samimi, Ph.D., M.P.H.
Snyder, Michael P.

Stanford University
United States

Precancer Atlas of Familial Adenomatous Polyposis 3U2CCA233311-01S1 Richard Mazurchuk, Ph.D.
Smith, Ellen Mary Lavoie

University Of Alabama At Birmingham
United States

Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study 5R01CA235726-07
Smith, Jennifer Susan

Univ Of North Carolina Chapel Hill
United States

UNC CASCADE Network Research Base 5UG1CA275403-02 Silvina Frech, Ph.D., M.S.
Smalley, Keiran

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Defining and targeting the epigenetic programs involved in melanoma development 5R21CA267141-02 PAR-20-292 (R21 Clinical Trial Optional) Winfred Malone, Ph.D., M.P.H.
Slager, Susan L

Mayo Clinic Rochester
United States

The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL) 5R01CA258465-02
Skubitz, Amy Patrice

University Of Minnesota
United States

A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detection 5R01CA262153-03 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Skates, Steven J

Massachusetts General Hospital
United States

Proteomic Analyses of Serial Prediagnostic PLCO Serum in Cases and Controls to Identify Early Detection Ovarian Cancer Biomarkers Rising in a Substantial Fraction of Cases and Stable in Most Controls 5U01CA260758-03 PAR-18-913 (U01 Clinical Trial Not Allowed)
Skates, Steven J

Massachusetts General Hospital
United States

Genome-wide methylation and proteomic analysis of uterine lavage and cervical swab for early detection of ovarian cancer 5U2CCA271871-02 Christos Patriotis, Ph.D., M.Sc.